#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodegenerative disorder Ewing's sarcoma Chondrodystrophy Factor IX deficiency Spinal cord injury Primary myelofibrosis Iron overload Hereditary optic atrophy Crohn's disease Keratosis follicular Neuroendocrine carcinoma of the skin Myelodysplastic syndrome with excess blasts Insulinoma Non-Hodgkin's lymphoma refractory Colon cancer More trials…

    Learn about Rare Diseases

    Fabry’s disease – Diagnostics Vascular malformation – Trials in Disease Sarcoidosis Combined immunodeficiency – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Angiosarcoma non-metastatic – Basic Information Alagille syndrome – Life with Disease Focal segmental glomerulosclerosis – Life with Disease Ewing’s sarcoma – Life with Disease Angiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ciclesonide Escitalopram UDONITRECTAG Warfarin GSKVX000000017986 Wve-006 Tabelecleucel Acetylcysteine Mitoxantrone Hydrochloride 177LU-FAP-2286 AZD0516 Evg321 S230815-2 Pp1493 Suvecaltamide Dorocubicel Ruxolitinib Cetrimide Lutropin Alfa Maraviroc More therapies…

    Learn about Your Condition

    Skin bacterial infection Cholestatic pruritus Thrombectomy Ventricular extrasystoles Adenovirus infection Renal cancer stage IV Ewing's sarcoma Amnestic disorder HER2 protein overexpression Petit mal epilepsy Malignant melanoma stage IV Propionic acidaemia Hepatitis alcoholic Herpes virus infection Chorioretinitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z…

Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z o.o.

Ul. Marcelinska 92, Poznan, 60-324, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatomyositis
    • Polymyositis
    Investigated Drugs:
    • Betamethasone
    • Budesonide
    • CHLOROQUINE PHOSPHATE
    Belgium Bulgaria France Germany Hungary Italy +4

  • Study on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anhydrous Caffeine
    • Camphor
    • Dapirolizumab Pegol
    Belgium Denmark France Germany Greece Italy +3

  • Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anhydrous Caffeine
    • Camphor
    • Dapirolizumab Pegol
    Belgium Bulgaria Czechia Denmark France Germany +7

  • ICP-332 for Adults with Prurigo Nodularis

    Recruiting

    2 1
    Austria Belgium France Germany Poland

  • A study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.

    Recruiting

    3 1 1
    Investigated Drugs:
    • Lebrikizumab
    Bulgaria France Germany Italy Poland Spain

  • Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

    Recruiting

    2 1
    Investigated Diseases:
    • Interstitial lung disease
    • Systemic scleroderma
    Investigated Drugs:
    • Bi 1015550
    • Amlitelimab
    Austria Belgium Denmark France Germany Italy +5

  • A Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Diabetes mellitus
    • Obesity
    • Overweight
    Czechia Germany Greece Poland

  • ELV001 for Active Rheumatoid Arthritis in Patients with Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Bulgaria Czechia Hungary The Netherlands Poland Spain

  • A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    Bulgaria Croatia Czechia Estonia Finland France +10

  • Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Etanercept
    Bulgaria Hungary Poland Romania
Previous Page
1 2 3 4 5 … 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!